Elevated Financial Group »

Arcutis Biotherapeutics shares owned by Elevated Financial Group

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Elevated Financial Group from 13F filings

Historical chart of Elevated Financial Group investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Elevated Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Elevated Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $565k 20k 29.04

More positions owned by Elevated Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Core Msci Emkt (IEMG)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Msci Usa Mmentm (MTUM)
Ishares Tr Mbs Etf (MBB)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Core Intl Aggr (IAGG)

View all positions for Elevated Financial Group

Top funds holding Arcutis Biotherapeutics

Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics